| Literature DB >> 24498421 |
Chelsea G Himsworth1, Ruth R Miller2, Vincent Montoya3, Linda Hoang4, Marc G Romney5, Ghada N Al-Rawahi6, Thomas Kerr7, Claire M Jardine8, David M Patrick9, Patrick Tang4, J Scott Weese8.
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is an important cause of multi-drug-resistant infections in people, particularly indigent populations. MRSA can be transmitted between people and domestic animals, but the potential for transmission between people and commensal pests, particularly rodents, had not been investigated. The objective of this study was to identify the presence and characterize the ecology of MRSA in rats (Rattus spp.) from in an impoverished, inner-city neighborhood. Oropharyngeal swabs were collected from rats trapped in 33 city blocks and one location within the adjacent port. Bacterial culture was performed and MRSA isolates were characterized using a variety of methods, including whole-genome sequencing (WGS). The ecology of MRSA in rats was described using phylogenetic analysis, geospatial analysis, and generalized linear mixed models. MRSA was identified 22 of 637 (3.5%) rats tested, although prevalence varied from 0 - 50% among blocks. Isolates belonged to 4 clusters according to WGS, with the largest cluster (n = 10) containing isolates that were genetically indistinguishable from community-acquired USA300 MRSA strains isolated from people within the study area. MRSA strains demonstrated both geographic clustering and dispersion. The odds of an individual rat carrying MRSA increased with increased body fat (OR = 2.53, 95% CI = 1.33-4.82), and in the winter (OR = 5.29, 95% CI = 1.04-26.85) and spring (OR = 5.50, 95% CI = 1.10-27.58) compared to the fall. The results show that urban rats carried the same MRSA lineages occurring in local human and/or animal populations, supporting recent transmission from external sources. MRSA carriage was influenced by season, most likely as a result of temporal variation in rat behavior and rat-human interactions.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24498421 PMCID: PMC3912160 DOI: 10.1371/journal.pone.0087983
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of 22 MRSA isolated obtained from wild Norway rats.
| Rat number | Block | Trap | Date | Cluster |
| MLST | PVL | Ampicillin | Cefoxitin | Chloramphenicol | Ciprofloxacin | Clindamycin | Daptomycin | Erythromycin | Gentamicin | Levofloxacin | Linezolid | Moxifloxicin | Nitrofurantoin | Oxacillin +2% NaCl | Penicillin | Quinupristin/dalfopristin | Rifampin | Streptomycin | Tetracycline | Tigec ycline | Trimethoprim/sulphamethoxazole | Vancomycin |
| M11-82 | 05 | 018A | 11/10/11 | 1 | t008 | 8 | Pos | >8 | >6 | 16 | ≤1 | ≤0.5 | ≤0.5 | >4 | ≤2 | >4 | 4 | 2 | ≤32 | >4 | >8 | ≤0.5 | ≤0.5 | ≤1000 | ≤2 | 0.25 | ≤0.5 | 1 |
| M11-86 | 06 | 010 | 02/11/11 | 1 | t008 | 8 | Pos | >8 | >6 | 16 | >2 | >2 | ≤0.5 | >4 | ≤2 | >4 | 4 | 2 | ≤32 | >4 | >8 | 1 | 1 | ≤1000 | ≤2 | 0.25 | ≤0.5 | 2 |
| M12-83 | 16 | 006 | 10/02/12 | 1 | t008 | 8 | Pos | >8 | >6 | 16 | >2 | ≤0.5 | ≤0.5 | >4 | ≤2 | >4 | 4 | 2 | ≤32 | >4 | >8 | ≤0.5 | 1 | ≤1000 | ≤2 | 0.25 | ≤0.5 | 2 |
| M12-84 | 19 | 002 | 10/02/12 | 1 | t008 | 8 | Pos | >8 | >6 | 8 | >2 | ≤0.5 | ≤0.5 | >4 | ≤2 | >4 | 4 | 2 | ≤32 | >4 | >8 | ≤0.5 | ≤0.5 | ≤1000 | >16 | 0.25 | ≤0.5 | 1 |
| M12-118 | 19 | 004 | 16/02/12 | 1 | t008 | 8 | Pos | >8 | >6 | 8 | >2 | 1 | 1 | 0.5 | ≤2 | >4 | 2 | 2 | ≤32 | >4 | >8 | ≤0.5 | 2 | ≤1000 | ≤2 | 0.25 | ≤0.5 | 1 |
| M12-119 | 19 | 012 | 16/02/12 | 1 | t008 | 8 | Neg | >8 | >6 | 16 | >2 | 1 | ≤0.5 | >4 | ≤2 | 4 | ≤1 | 1 | ≤32 | >4 | >8 | ≤0.5 | ≤0.5 | ≤1000 | ≤2 | 0.25 | ≤0.5 | 1 |
| M12-121 | 19 | 003 | 17/02/12 | 1 | t818 | 8 | Pos | >8 | >6 | 8 | >2 | 2 | ≤0.5 | 0.5 | ≤2 | >4 | 2 | 2 | ≤32 | >4 | >8 | ≤0.5 | 1 | ≤1000 | ≤2 | 0.25 | ≤0.5 | 1 |
| M12-85 | 19 | 012 | 08/02/12 | 1 | tNew | 8 | Pos | >8 | >6 | 8 | >2 | ≤0.5 | ≤0.5 | >4 | ≤2 | >4 | 2 | 2 | ≤32 | >4 | >8 | ≤0.5 | ≤0.5 | ≤1000 | ≤2 | 0.25 | ≤0.5 | 1 |
| M12-117 | 19 | 011 | 17/02/12 | 1 | tNew | 8 | Pos | >8 | >6 | 8 | >2 | ≤0.5 | ≤0.5 | >4 | ≤2 | >4 | 2 | 2 | ≤32 | >4 | >8 | ≤0.5 | ≤0.5 | ≤1000 | ≤2 | 0.25 | ≤0.5 | 1 |
| M12-559 | 28 | 005 | 02/05/12 | 1 | t008 | 8 | Pos | >8 | >6 | 16 | >2 | ≤0.5 | 2 | >4 | ≤2 | >4 | 4 | 4 | ≤32 | >4 | >8 | 1 | ≤0.5 | ≤1000 | ≤2 | 0.25 | ≤0.5 | 2 |
| M11-81 | 05 | 021B | 11/10/11 | 2 | t034 | 398 | Neg | >8 | >6 | 16 | ≤1 | >2 | 1 | >4 | 4 | ≤0.25 | 2 | ≤0.25 | ≤32 | >4 | >8 | 4 | 2 | ≤1000 | >16 | 0.25 | ≤0.5 | 1 |
| M11-215 | 06 | 017 | 07/12/11 | 2 | t034 | 398 | Neg | >8 | >6 | 8 | ≤1 | ≤0.5 | ≤0.5 | ≤0.25 | ≤2 | 0.5 | 2 | ≤0.25 | ≤32 | >4 | >8 | ≤0.5 | ≤0.5 | ≤1000 | >16 | 0.25 | ≤0.5 | 1 |
| M12-473 | 25 | 010 | 19/04/12 | 2 | t034 | 398 | Neg | >8 | >6 | 8 | ≤1 | ≤0.5 | ≤0.5 | ≤0.25 | ≤2 | ≤0.25 | 4 | ≤0.25 | ≤32 | >4 | >8 | ≤0.5 | ≤0.5 | ≤1000 | >16 | 0.25 | ≤0.5 | 0.5 |
| M12-474 | 27 | 004 | 18/04/12 | 2 | t034 | 398 | Neg | >8 | >6 | 8 | ≤1 | ≤0.5 | ≤0.5 | ≤0.25 | ≤2 | ≤0.25 | 2 | ≤0.25 | ≤32 | >4 | >8 | ≤0.5 | ≤0.5 | ≤1000 | >16 | 0.25 | ≤0.5 | 0.5 |
| M12-475 | 27 | 008 | 17/04/12 | 2 | t034 | 398 | Neg | >8 | >6 | 8 | ≤1 | ≤0.5 | ≤0.5 | ≤0.25 | ≤2 | ≤0.25 | 2 | ≤0.25 | ≤32 | >4 | >8 | ≤0.5 | ≤0.5 | ≤1000 | >16 | 0.25 | ≤0.5 | 0.5 |
| M12-560 | 30 | 012 | 17/05/12 | – | t267 | – | Neg | >8 | >6 | 8 | 2 | ≤0.5 | ≤0.5 | 0.5 | ≤2 | 0.5 | 2 | ≤0.25 | ≤32 | >4 | >8 | ≤0.5 | ≤0.5 | ≤1000 | ≤2 | 0.12 | ≤0.5 | 1 |
| M12-561 | 30 | 011 | 17/05/12 | 4 | t267 | 97 | Neg | >8 | >6 | 8 | ≤1 | ≤0.5 | ≤0.5 | 0.5 | ≤2 | 0.5 | 2 | ≤0.25 | ≤32 | >4 | >8 | ≤0.5 | ≤0.5 | ≤1000 | ≤2 | 0.25 | ≤0.5 | 1 |
| M12-562 | 30 | 012 | 16/05/12 | 4 | t267 | 97 | Neg | >8 | >6 | 8 | ≤1 | ≤0.5 | ≤0.5 | 0.5 | ≤2 | 0.5 | 2 | ≤0.25 | ≤32 | >4 | >8 | ≤0.5 | ≤0.5 | ≤1000 | ≤2 | 0.25 | ≤0.5 | 1 |
| M12-563 | 30 | 003 | 18/05/12 | 4 | t267 | 97 | Neg | >8 | >6 | 8 | ≤1 | ≤0.5 | ≤0.5 | 0.5 | ≤2 | 0.5 | 2 | ≤0.25 | ≤32 | >4 | >8 | ≤0.5 | ≤0.5 | ≤1000 | ≤2 | 0.25 | ≤0.5 | 1 |
| M12-564 | 30 | 008 | 16/05/12 | 4 | t267 | 97 | Neg | >8 | >6 | 8 | ≤1 | ≤0.5 | ≤0.5 | 0.5 | ≤2 | 0.5 | 2 | ≤0.25 | ≤32 | >4 | >8 | ≤0.5 | ≤0.5 | ≤1000 | ≤2 | 0.25 | ≤0.5 | 1 |
| M12-120 | 19 | 008 | 16/02/12 | 3 | t002 | 105 | Neg | >8 | >6 | 16 | >2 | >2 | ≤0.5 | >4 | ≤2 | >4 | 2 | >4 | ≤32 | >4 | >8 | ≤0.5 | ≤0.5 | ≤1000 | ≤2 | 0.25 | ≤0.5 | 1 |
| M12-472 | 24 | 010 | 20/04/12 | 3 | t002 | 105 | Neg | >8 | >6 | 8 | >2 | ≤0.5 | ≤0.5 | >4 | ≤2 | >4 | 2 | >4 | ≤32 | >4 | >8 | ≤0.5 | ≤0.5 | ≤1000 | ≤2 | 0.25 | ≤0.5 | 1 |
Not available.
Three repeat insertion from t008.
One variant position different from sequence type specified.
Minimum inhibitory concentration (µg/ml). Breakpoints for antimicrobial susceptibility (S = sensitive, R = resistant): Ampicillin: S≤0.25/R≥0.5, Cefoxitin: R>4, Chloramphenicol: S≤8/R≥32, Ciprofloxacin: S≤1/R≥4, Clindamycin: S≤0.5/R≥4, Daptomycin: S≤4/R≥16, Erythromycin: S≤0.5/R≥8, Gentamycin: S≤4/R≥16, Levofloxacin: S≤1/R≥4, Linezolid: S≤4/R≥8, Moxifloxacin: S≤0.5/R≥2, Nitrofurantoin: S≤32/R≥128, Oxacillin +2% NaCl: S≤2/R≥4, Penicillin: S≤0.12/R≥0.25, Quinpristen/dalfopristin: S≤1/R≥4, Rifampin: S≤1/R≥2, Streptomycin: Not available, Tetracycline: S≤4/R≥16, Tigecycline: S≤0.5, Trimethoprim/Sulphamethoxazole: S≤2/R≥4, Vancomycin: S≤2/R≥16.
Figure 1Prevalence of MRSA-positive and -negative rats in each city block.
Relationship between MRSA-status, season, and morphometric characteristics among a population of wild Norway rats.
| Characteristic | MRSA-positive n (%) | MRSA-negative n (%) | Unadjusted odds ratio (95% CI) | Adjusted odds ratio (95% CI) | |
|
| |||||
| Fall | 3 (13.6) | 232 (40.1) | Ref | Ref | |
| Winter | 9 (40.9) | 126 (40.9) | 5.52 (1.62 – 25.52) | 5.29 (1.04 – 26.85) | |
| Spring | 10 (45.5) | 212 (36.6) | 3.65 (1.10 – 16.43) | 5.50 (1.10 – 27.58) | |
| Summer | 0 (0) | 9 (1.6) | – | – | |
|
| |||||
| Female | 11 (50.0) | 247 (42.7) | Ref | ||
| Male | 11 (50.0) | 324 (56.0) | 0.76 (0.32 – 1.81) | ||
|
| |||||
| Immature | 5 (22.7) | 180 (34.1) | Ref | ||
| Mature | 17 (77.3) | 348 (65.9) | 1.76 (0.68 – 5.42) | ||
|
| |||||
| Median (IQR) | 20.9 (6.4 – 33.0) | 15.7 (6.6 – 26.1) | 1.03 (1.00 – 1.07) | ||
|
| |||||
| Median (IQR) | 20.0 (13.1 – 22.0) | 18.0 (13.5 – 21.0) | 1.07 (0.97 – 1.19) | ||
|
| |||||
| Median (IQR) | 2.0 (1.0 – 2.0) | 1.0 (0.0 – 2.0) | 2.22 (1.27 – 4.16) | 2.53 (1.33 – 4.82) |
Frequencies and percentages may not add to 100% because of exclusion of rats with missing data for the variable in question.
Reference category.
Insufficient power for accurate estimation.
Figure 2Maximum likelihood phylogenetic tree of all rat MRSA samples.
2a: Branch color represents cluster: Green = Cluster 1; Pink = Cluster 2; Yellow = Cluster 3; Orange = Cluster 4. Labels give isolate ID and date. MLST, spa type, and presence of PVL shown in right columns. Abbreviations: ST = Sequence Type; tNew = New spa type with 3 repeat insertion from t008. Scale bar represents the average number of substitutions per site. 2b: Maximum likelihood phylogenetic tree of all rat and human MRSA ST8 samples. Labels give isolate ID, sample location and date. Text color represents sample isolation location: Red = Rat; Dark blue = Human DTES; Pale blue = Human other. MLST, spa type and presence of PVL shown in right columns. Abbreviations: DTES = Downtown East Side; CA = Community-acquired; HA = Hospital-acquired; ST = Sequence Type; tNew = New spa type with 3 repeat insertion from t008. Scale bar represents the average number of substitutions per site.
Figure 3Geographic distribution of MRSA-positive rats.
Inset = Map of Vancouver with location of study site.